FOR IMMEDIATE RELEASE
Media Contact: Robert F. Riess, COO / CMO - OrangeHook, Inc.
InXite and OrangeHook Announce Strategic Relationship for the Healthcare Market
InXite Health Systems and OrangeHook, Inc. Launch “InXite Health OS”
Partners to Provide an Integrated Continuum of Care Solution for the Healthcare Market driven by chronic care management (CCM) program.
Columbus, Ohio and MINNEAPOLIS –October 19, 2017 – InXite Health Systems (“IHS”) a, Columbus, Ohio healthcare IT firm and OrangeHook, Inc.: OTCQB: ORHK (“OrangeHook”), a Wayzata, Minnesota software solutions company focused on identity solutions, announced today that they have reached an agreement forming a major strategic relationship for delivery of healthcare infrastructure solutions to the global healthcare market. The strategic product offerings will be based on each of the parties’ proprietary technologies, and will include a virtually integrated continuum of care platform powered by InXite’s advanced value-based care platform and OrangeHook’s patient identification and payments technologies. The bundled software solution uniquely empowers government agencies, payors, hospitals and healthcare providers to more effectively and cost-efficiently deliver patient-centered, value-based care and data-driven decision capabilities which are critical for improving patient outcomes, chronic care management, hospital readmissions and quality scores. The initial focus will be on providing CCM services approximately 2 million patients under managed services agreements with a variety of large health systems, Independent Physician Associations, State Healthcare Collaboratives, and Physician and Accountable Care Organizations across multiple states including Florida, Alabama, Ohio, West Virginia, Michigan, Arizona and California.
The comprehensive solution enables the data that is traditionally siloed within various hospital electronic medical records (EMR), practice management systems, pharmacy management systems and health plans to now be portable with the patient in a highly secure manner across the continuum of care. The solution will be branded by InXite as “InXite Health OS” (Health Operating System) and will deliver unparalleled capabilities that will transform the patient healthcare experience. InXite Health OS consists of advanced data interoperability, care coordination, patient engagement and quality reporting, and analytic capabilities from the InXite SmartCare Platform and leverages OrangeHook’s iChip® technology to power the “InXite Patient HealthCard.” OrangeHook’s patented iChip technology securely authenticates user access to unified patient information, will create an audit trail of patient encounters across the continuum of care and will provide “read and write” capabilities between the Patient HealthCard and the patients care team for easier and more effective exchange of information. The iChip will also provide the ability to deliver future capabilities to users such as advanced fraud protection and payment capabilities.
“The InXite/OrangeHook Health OS and Patient Health Card is analogous to the “ATM card for healthcare,” said James Paat, Chairman & CEO of InXite. “As healthcare is rapidly transforming from volume-based to value-based delivery and payment models, InXite Health OS provides the critical functionality needed to effectively and cost efficiently support value-based care programs including chronic care management, transition of care management and readmission and quality improvement initiatives.”
“Our strategic relationship and integrated solution is truly driven by customer demand in the healthcare market,” James L. Mandel, CEO of OrangeHook, Inc. stated. “Healthcare providers need comprehensive patient data to drive better patient outcomes and lower costs in a flexible and patient-centric manner, which are offered by the OrangeHook and InXite applications. We believe that the benefits of superior big data efficiency, artificial intelligence (“AI”), mobility, and built-in data protection that is compliant with healthcare standards are achieved only with the OrangeHook and InXite solutions. This comprehensive solution focuses on patient care within the scope of the healthcare driven continuum of care, provides both InXite and OrangeHook immediate revenue opportunities and applications that the market is already embracing.”
InXite is a Columbus, Ohio-based healthcare innovation company. InXite executive personnel possess diverse experience across many vertical industries including financial services, supply chain management, national security & public safety, and healthcare. InXite has been recognized as one the 50 fastest growing healthcare technology companies in the US; as one of the 10 most disruptive technologies transforming healthcare; and as one of the most promising population health management companies of 2017. For more information please visit www.inxitehealth.com
OrangeHook Inc., is a global leader in identity solutions. Through its suite of proprietary technologies, OrangeHook helps health, government, and corporate entities with cloud, card and mobile based validation, accreditation, and verification services. OrangeHook’s solutions can be implemented quickly, and in a technologically agnostic manner. OrangeHook holds multiple patents and trademarks. OrangeHook solutions are HIPAA and HITECH compliant. For more information, visit www.orangehook.com.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1996 that represent OrangeHook management’s expectations or beliefs about future events relating to its planned joint venture with SCG. Forward-looking statements are identifiable by words such as “believe”, “intend”, “anticipate”, “expect”, “plan”, “will”, “may”, and other similar expressions. Forward-looking statements made in this presentation, which relate to OrangeHook’s agreement with InXite, involve known and unknown risks and uncertainties that may cause the actual results to differ materially from those expected and stated in this announcement. Actual results could differ if: i) the economy, and particularly the healthcare segments of the economy that impact the proposed relationship, does not grow and perform at least as well as forecast. In addition, actual results could differ as a result of, among other things, i) the expected immediate revenue as expected; ii) a lack of market acceptance of the integrated solution; iii) unanticipated technical or cost issues associated with integration of the parties’ solutions. It is not possible to foresee or identify all factors that could cause actual results to differ from expected results. As such, you should not consider any list of such factors to be an exhaustive statement of all risks, uncertainties or potential inaccurate assumptions. For additional information on factors that could cause our actual results to differ and for more specific information about our business and the risks associated with it, please review the periodic reports that OrangeHook files publicly with the Securities and Exchange Commission. Forward-looking statements made herein speak only as to the date of this release and, except as expressly required by the securities laws, we undertake no obligation to publicly update any forward-looking statements made herein.